Abstract:Hepatocellular carcinoma (HCC) is one of the most common cancers and shows a propensity to metastasize and infiltrate adjacent and more distant tissues. However, the mechanisms that contribute to tumor metastasis remain unclear. Here we evaluate the effect of Argonaute2 (Ago2), a member of the Ago gene family that plays a role in short interfering RNA‐mediated gene silencing, on HCC tumorigenesis, and metastasis. We found that Ago2 was frequently up‐regulated in HCC specimens compared to that in corresponding adjacent nontumor liver. Interestingly, Ago2 overexpression can promote proliferation, colony formation in an anchor‐independent manner, migration, tumorigenicity, and metastasis of HCC cells in vivo; in contrast, Ago2 knockdown can restrict anchor‐independent colony formation, migration, and tumor metastasis of HCC cells in vivo. However, known microRNAs related to tumor metastasis appeared not be deregulated with Ago2 overexpression in HCC cells; even the knockdown of Dicer, which is responsible for microRNA biosynthesis, did not abolish the actions of Ago2 in HCC cells. Significantly, focal adhesion kinase (FAK), a well‐known molecule associated with tumor metastasis, was up‐regulated as a result of Ago2 overexpression. Chromatin immunoprecipitation assay showed that Ago2 can bind to the FAK promoter and then trigger its transcription. Moreover, an increased DNA copy number of Ago2 on chromosome 8q24, one of the most frequent DNA amplified regions, was validated and shown by way of fluorescence in situ hybridization. Conclusion: Our data demonstrate that Ago2 overexpression, as a result of genomic DNA amplification, promotes HCC tumorigenesis and metastasis by way of up‐regulation of FAK transcription, thereby providing new insight into HCC progression and Ago2 function. (HEPATOLOGY 2013)

Overexpression of Human Argonaute2 Inhibits Cell and Tumor Growth

Essential and Overlapping Functions for Mammalian Argonautes in Microrna Silencing.

Effects of Argonaute Subfamily Proteins on Cell Cycle of Human Cancer Cells

Acetylation of AGO2 promotes cancer progression by increasing oncogenic miR-19b biogenesis

Argonaute2 Promotes Tumor Metastasis by Way of Up-Regulating Focal Adhesion Kinase Expression in Hepatocellular Carcinoma

A previously unknown Argonaute 2 variant positively modulates the viability of melanoma cells

Oncogenic Roles and Mechanisms of Lncrna AGAP2-AS1 in Human Solid Tumors.

Argonaute 2 Is Up-Regulated In Tissues Of Urothelial Carcinoma Of Bladder

CRISPR-Cas9 Mediated AGO2 Knockout inhibits tumorigenesis in human colorectal cancer cells

Ago1 Interacts with Rna Polymerase Ii and Binds to the Promoters of Actively Transcribed Genes in Human Cancer Cells

Argonaute Proteins: Potential Biomarkers for Human Colon Cancer

Impaired AGO2/miR-185-3p/NRP1 Axis Promotes Colorectal Cancer Metastasis

Up-regulation of Ago2 expression in gastric carcinoma

AGO2 protein: a key enzyme in the miRNA pathway as a novel biomarker in adrenocortical carcinoma

Increased Argonaute 2 Expression in Gliomas and its Association with Tumor Progression and Poor Prognosis

Ago2/CAV1 interaction potentiates metastasis via controlling Ago2 localization and miRNA action

Loss of Lamin A leads to the nuclear translocation of AGO2 and compromised RNA interference

Essential Role for Argonaute2 Protein in Mouse Oogenesis

Anti-Adenoviral Effect of Human Argonaute 2 Alone and in Combination with Artificial microRNAs

Cell Type- and Tissue Context-dependent Nuclear Distribution of Human Ago2

Argonaute 2 in Cell-Secreted Microvesicles Guides the Function of Secreted Mirnas in Recipient Cells